Clinuvel AG

Suisse

 
Quantité totale PI 5
Rang # Quantité totale PI 308 907
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 660 322

Brevets

Marques

0 0
0 0
5 0
0
 
Dernier brevet 2017 - Inflammatory disease
Premier brevet 2012 - Hexapeptide with improved activi...

Derniers inventions, produits et services

2015 Invention Inflammatory disease. The present invention is directed to alpha-MSH analogues for treatment of ...
Invention New indication for alpha-msh analogues. The present invention is directed to alpha-MSH analogues...
Invention New indication for alpha-msh analogues. The present invention is directed to alpha-MSH analogues ...
Invention Inflammatory disease. The present invention is directed to alpha-MSH analogues for treatment of i...
2014 Invention Alpha-msh analogues for use in the treatment of psoriasis. The present invention relates to alpha...
Invention Alpha-msh analogues for use in the treatment of hailey-hailey disease. The present invention rela...
Invention Alpha-msh analogues for use in bullous disease. The present invention relates to alpha-MSH analog...
2012 Invention Hexapeptide with improved activity in the repair of cellular dna of dermal cells. The present in...